Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reexamination Certificate
2007-06-26
2007-06-26
Lukton, David (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
C530S308000, C530S345000, C514S002600, C514S012200
Reexamination Certificate
active
10285079
ABSTRACT:
The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5380872 (1995-01-01), Sugg et al.
patent: 5512549 (1996-04-01), Chen et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5912229 (1999-06-01), Thim et al.
patent: 0 658 568 (1995-06-01), None
patent: 0 708 179 (1996-04-01), None
patent: WO 90/11296 (1990-10-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 95/07931 (1995-03-01), None
patent: WO 95/31214 (1995-11-01), None
patent: WO 96/29342 (1996-09-01), None
patent: WO 96/29344 (1996-09-01), None
patent: WO 97/31943 (1997-09-01), None
patent: WO 98/08531 (1998-05-01), None
patent: WO 98/08873 (1998-05-01), None
patent: WO 98/19698 (1998-05-01), None
patent: WO 90/11296 (1999-04-01), None
Marx J. “Obesity gene discover may help solve weighty problem” (news) . Science, (Dec. 2, 1994) 266 (5190) pp. 1477-1478.
Zhang et al. “Positional cloning of the mouse obese gene and its human Homologue”. Nature, (Dec. 1, 1994) 372 (6505) pp. 425-432.
Rink T.J., “In search of a satiety tactor”. Nature, (Dec. 1, 1994) 372 (6505) pp. 406-407.
Woods et al., “Signals that regulate food intake and energy Homeostasis”. Science, 280:1378-1383, May 29, 1998.
Thorens T. “Glucagon-like peptide-1 and control of insulin secretion”. Diabete & Metabolisme (Paris) . 1995, 21, pp. 311-318.
Henriksen et al. Peptide amidation by chemical protein engineering A combination of encymic and photochemical synthesis. J. AM Chem. (1992), 114 (5) , pp. 1876-1877.
Wang et al. “Glucagon-like peptide-1 is a physiological incretin in rat”. J. Clin. Invest., (Jan. 1995) (1) 417-421.
Bell et al. “Exon duplication and divergence in the human Preproglucagon gene”. Nature, (1983) Jul. 28-Aug. 3).
Wettergren et al. “Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man”. Digest. Dis. Sci., (Apr. 1993) 38 (4) 665-673.
Suzuki et al. “Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagons-like peptide-1 on insulin and glucagons release from the isolated perfused rat pancreas”. Endocrinology, (Dec. 1989) 125 (6) 3109-3114.
Navarro et al., Journal of Neurochemistry, vol. 67, No. 5, pp. 1982-1991 (Nov. 1996).
Turton et al., Nature, vol. 379, pp. 69-72 (Jan. 4, 1996).
Drugs of the Future 2001, vol. 26(7) :pp. 677-685 (2001).
M. Gutniak et al., Antidiabetogenic Effect of Glucagon-Like Peptide (7-36) Amide in Normal Subjects and Patients with Diabetes Mellitus New England Journal of Medicine vol. 326 No. 20 pp. 1316-1322 (1992).
M. Navarro et al., Changes in Food Intake Induced by GLP-1(7-36) Amide In the Rat, Abstracts of the 15thInternational Diabetes Federation Congress, Nov. 6-11, 1194 Kobe, poster presentation 11A 5PP1295.
R. Schick et al., “Glucagon-like peptide 1-a novel brain peptide Involved in feeding regulation” Obesity in Europe 1993, Chapter 53, pp. 363-367.
P.D. Lambert et al., “A Role for GLP-1(7-36) NH2in the Central Control Of Feeding Behavior” Digestion 1994; vol. 54. pp. 360-361.
“New Appetite Suppresser May Help Cut Pounds”, CNN Food and Health Web Site, Jan. 5, 1996.
B. Willms et al., “Gastric Emptying, Glucose Responses, and Insulin Secretion after a Liquid Test Meal : Effects of Exogenous Glucagon-Like Peptide-1 (GLP-1) (7-36) Amide in Type 2 (Noninsulin-Dependent) Diabetic Patients” Journal of Clinical Endocrinology and Metabolism vol. 8 No. 1 (1996) pp. 327-332.
C. L. Broderick et al., Abstract 664 Effect of Sub-Chronic Administrattion of GLP-1 (7-37) OH on Beta Cell Failure in Zucker Diabetic Rats.
M. Tang-Christensen et al., “Central Administration of GLP-1 (7-36) Amide Inhibits Food and Water Intake in Rats”, The American Physiological Society (1996) 271 :R848-R856.
Zhili Wang et al., “Glucagon-like Peptide-1 Is a Physiological Incretin in Rat” J. Clin. Invest. The American Society for Clin Invest., vol. 95. pp. 417-421, Jan. (1995).
C. Ørskov, “Glucagon-like peptide-1, a new hormone of the entero-insular Axis” Diabetologia vol. 35:pp. 701-711 (1992).
Gutzwiller et al., Abstract “Glucagon-like peptide-1 is a physiologic regulator of food intake in human” Gastroenterology (1997) vol. 12 (4, Supp.S) : PA1153.
Ranganath et al., “Attenuated GLP-1 secretion in obesity: cause or con-Sequence” Gur vol. 38: pp. 916-919 (1996).
Huusfeldt Per Olaf
Knudson Liselotte Bjerre
Nielsen Per Franklin
Began Marc A.
Bork Richard W.
Green Reza
Lukton David
Novo Nordisk A S
LandOfFree
Derivatives of GLP-1 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of GLP-1 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of GLP-1 analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3869570